Biocartis Archives

News and Trends 3 Jun 2019

Belgian and US Biotechs Team up to Reduce CAR T Side Effects

The diagnostics company Biocartis is collaborating with Kite Pharma to monitor the progress of CAR T-cell therapies in patients to better manage side effects. CAR T-cell therapies have revolutionized the way we treat cancer. Instead of giving the patient a classical drug, companies can inject them with living, genetically engineered cells that kill cancer cells. […]

June 3, 2019 - 3 minutesmins - By Jonathan Smith

News and Trends 9 Jan 2018

Biocartis and Amgen Shake Hands on Another Cancer Diagnostics Deal

Biocartis will use its expertise in molecular diagnostics to produce a companion diagnostic test for Amgen’s upcoming cancer drug. Biocartis has signed its second agreement with US pharma giant, Amgen, to develop a companion diagnostic to test the suitability of a drug for a specific patient. Both deals will make use of Biocartis’ Idylla platform, a fully automated […]

January 9, 2018 - 1 minutemin - By Alex Dale

News and Trends 29 Nov 2017

Belgian Firm Raises €80M for Rapid Infection and Cancer Tests

Biocartis is aiming to raise funds through a private placement of shares in order to support sales and further development of its rapid cancer tests. Based in Mechelen, Belgium, Biocartis focuses on developing fast, easy-to-use diagnostics. In order to boost its molecular diagnostics technology, the company launched a private equity placement of shares on Euronext […]

November 29, 2017 - 1 minutemin - By Clara Rodríguez Fernández

Best in Biotech 15 Mar 2017

What are the Best Countries to Recruit Biotech Talents in 2017?

Before the “who to recruit” phase, an important question is “where?” We ran through the top countries in which to look for talent in biotech and had a look at what you can expect from each cluster. For each one of them, we also referenced some data on the biotech, life science and research ecosystems to […]

March 15, 2017 - 10 minutesmins - By External Contributor

News and Trends 29 Apr 2015

Biocartis shakes Euronext with an IPO that raised €100M

Last Monday, Belgian Biocartis launched an IPO that quickly raised €100M; the offering was closed a week ahead of schedule. The unquestionable interest of the investors, both in Belgium and internationally, shows the company’s potential and the appeal of its technology. The company, which raised €64.5M in September in a private financial round, intends to […]

April 29, 2015 - 1 minutemin - By Lourdes Riquelme

Resources

Categories

The biggest private biotech investments in August 2024

Long non-coding RNAs: what’s behind the growing “dark genome” buzz?

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

Six biotech companies that could revolutionize obesity treatments

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us